Professional
Added to YB: 2024-04-04
Pitch date: 2024-03-29
SNN [bullish]
Smith & Nephew plc
+31.01%
current return
Author Info
No bio for this author
Company Info
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.
Market Cap
GBP 13.8B
Pitch Price
GBP 9.28
Price Target
38.00 (+213%)
Dividend
2.34%
EV/EBITDA
11.20
P/E
29.17
EV/Sales
2.79
Sector
Health Care Equipment and Supplies
Category
turnaround
Smith & Nephew Racks Up Consistent Operational Gains
SNN: Q4 solid finish to 2023. Orthopedics +5%, sports med & ENT strong. Op improvements driving margin expansion to 19.6% in H2 vs H1. Closing plants to consolidate mfg should help maintain. PT $38 on mid-single digit sports med & low-single orthopedics growth thru 2028. Risks: sub-scale in consolidating industry, C-suite turnover. Narrow moat on switching costs.
Read full article (9 min)